Jenny H.

Jenny H. has an extensive work experience history. Jenny is currently working as the Chief Strategy Officer at Actinium Pharmaceuticals, Inc. since June 2022. Prior to this, they served as the Head of Corporate Strategy at Immunomedics from 2017 to 2022. Before that, they held the position of Director, Corporate Strategy at Quest Diagnostics in 2016. From 2014 to 2016, they worked as the Senior Director, Strategy Consulting at The Advisory Board Company. Additionally, they were an Engagement Manager, Health and Life Sciences at Oliver Wyman from 2010 to 2014. Jenny'searlier roles include Senior Consultant at Navigant Consulting, Inc. from 2004 to 2007 and Product Analyst at McMaster-Carr in 2003.

Jenny H. holds an MBA from NYU Stern School of Business. Jenny also has a Master's in Public Administration with a focus on Health Policy & Management from NYU Robert F. Wagner Graduate School of Public Service. Additionally, they have a Bachelor's degree in Economics and Political Science from the University of Pennsylvania.